Latest Breaking News On - Jasmine cui - Page 8 : comparemela.com

InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CCR8 Monoclonal Antibody CM369

InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CCR8 Monoclonal Antibody CM369
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China
Guangzhou
Guangdong
Chengdu
Sichuan
Shanghai
Hong-kong
Beijing
Wuhan
Hubei
Nanjing
Jiangsu

InnoCare Releases 2022 Mid-Year Results and Business Highlights

InnoCare Releases 2022 Mid-Year Results and Business Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Guangzhou
Guangdong
China
Australia
Shanghai
United-states
Hong-kong
Beijing
Nanjing
Jiangsu
Macao
Macau-general

China approves InnoCare's orelabrutinib to treat Marginal Zone Lymphoma

China’s NMPA CDE has accepted InnoCare's sNDA for orelabrutinib to treat relapsed or refractory Marginal Zone Lymphoma (R/R MZL).

China
Jasmine-cui
National-reimbursement-drug
Multiple-sclerosis
Neuromyelitis-optica-spectrum-disorder
Primary-immune-thrombocytopenia

InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma in China

Press release content from Business Wire. The AP news staff was not involved in its creation.

China
Guangzhou
Guangdong
Beijing
United-states
Shanghai
Hong-kong
Nanjing
Jiangsu
Jasmine-cui
Jun-zhu
Chunhua-lu

InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China

InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China
Guangzhou
Guangdong
Beijing
United-states
Shanghai
Hong-kong
Nanjing
Jiangsu
Jasmine-cui
Innocare-pharma
Chunhua-lu